Member of the Association of American Physicians
John P. Kane mainly focuses on Internal medicine, Endocrinology, Biochemistry, Apolipoprotein B and Lipoprotein. His Endocrinology study combines topics from a wide range of disciplines, such as Gastroenterology and Apolipoprotein E. His Biochemistry research incorporates themes from Molecular biology and Beta.
His studies in Apolipoprotein B integrate themes in fields like Amino acid, Plasma protein binding, Ultracentrifuge, Molecular mass and Gel electrophoresis. The Lipoprotein study combines topics in areas such as Binding protein, Lipopolysaccharide binding protein and Metabolism. When carried out as part of a general Cholesterol research project, his work on Familial hypercholesterolemia is frequently linked to work in Potassium, therefore connecting diverse disciplines of study.
Internal medicine, Endocrinology, Biochemistry, Apolipoprotein B and Lipoprotein are his primary areas of study. John P. Kane frequently studies issues relating to Cardiology and Internal medicine. His work in the fields of Endocrinology, such as Reverse cholesterol transport, Hypertriglyceridemia and Hyperlipidemia, intersects with other areas such as In patient.
His Biochemistry study integrates concerns from other disciplines, such as Molecular biology and Chromatography. His work deals with themes such as Genetics and Gene, which intersect with Molecular biology. In his research on the topic of Apolipoprotein B, Apolipoproteins E and Lipoprotein lipase is strongly related with Very low-density lipoprotein.
John P. Kane focuses on Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Genetics. John P. Kane works mostly in the field of Internal medicine, limiting it down to topics relating to Cardiology and, in certain cases, Proportional hazards model. His work on Apolipoprotein B, Diabetes mellitus and Hypertriglyceridemia as part of general Endocrinology study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
John P. Kane interconnects SNP, Chromatography, Ultracentrifuge, Chylomicron and Postprandial in the investigation of issues within Apolipoprotein B. His work carried out in the field of Cholesterol brings together such families of science as Dyslipidemia, Efflux and Atorvastatin. His Lipoprotein research is under the purview of Biochemistry.
His primary areas of study are Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Genetics. His Internal medicine study combines topics in areas such as Hyperlipidemia, MEDLINE and Cardiology. John P. Kane has researched Endocrinology in several fields, including Lysosomal acid lipase deficiency and Vascular disease.
His Cholesterol research includes elements of Molecular biology, Apolipoprotein E and Simvastatin. His Lipoprotein study results in a more complete grasp of Biochemistry. John P. Kane works mostly in the field of Genetics, limiting it down to concerns involving Case-control study and, occasionally, Genome-wide association study, Cardiac conduction, Medical genetics, Quantitative trait locus and Expression quantitative trait loci.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
John P. Kane;Mary J. Malloy;Thomas A. Ports;Nancy R. Phillips.
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons
John P. Kane;David A. Hardman;Harold E. Paulus.
Proceedings of the National Academy of Sciences of the United States of America (1980)
A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci
Ying Liu;Cynthia Helms;Wilson Liao;Lisa C. Zaba.
PLOS Genetics (2008)
Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.
Richard J. Havel;John P. Kane;Moti L. Kashyap.
Journal of Clinical Investigation (1973)
A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins.
John P. Kane.
Analytical Biochemistry (1973)
Apolipoprotein L-I is the trypanosome lytic factor of human serum
Luc Vanhamme;Françoise Paturiaux-Hanocq;Philippe Poelvoorde;Derek P. Nolan;Derek P. Nolan.
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Clive R. Pullinger;Celeste Eng;Gerald Salen;Sarah Shefer.
Journal of Clinical Investigation (2002)
Apoprotein composition of very low density lipoproteins of human serum.
John P. Kane;Teizo Sata;Robert L. Hamilton;Richard J. Havel.
Journal of Clinical Investigation (1975)
Lipopolysaccharide (LPS)-binding Protein Is Carried on Lipoproteins and Acts as a Cofactor in the Neutralization of LPS
Mark M. Wurfel;Steven T. Kunitake;Henri Lichenstein;John P. Kane.
Journal of Experimental Medicine (1994)
Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans
R. J. Havel;J. P. Kane;E. O. Balasse;N. Segel.
Journal of Clinical Investigation (1970)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: